Abe S, Nakae J, Yasoshima K, Tajima T, Shinohara N, Murashita M, Satoh K, Koike A, Takahashi Y, Fujieda K
Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan.
Am J Med Genet. 1999 May 21;84(2):87-9.
We identified a DAX1 missense mutation, a substitution of arginine for leucine at codon 466 (Leu466Arg), in an infant with X-linked congenital adrenal hypoplasia (AHC). A heterozygous substitution, Leu466Arg, was also identified in his mother and sister. Since leucine at position 466 is well conserved among other orphan nuclear hormone receptor superfamilies and Leu466Arg was not detected among 50 normal Japanese control individuals, the mutation is most likely responsible for X-linked AHC. It is interesting to note that Leu466Arg among all mutations ever reported is located at the most C-terminal region of the DAX-1 protein. Most mutations identified previously were located in the C-terminal presumptive ligand binding domain. Hence, the C-terminal end of the DAX-1 protein may play an important role in the biological function, such as in normal adrenal embryogenesis.
我们在一名患有X连锁先天性肾上腺发育不全(AHC)的婴儿中发现了一个DAX1错义突变,即第466密码子处的亮氨酸被精氨酸取代(Leu466Arg)。在他的母亲和姐姐中也发现了杂合性替代Leu466Arg。由于第466位的亮氨酸在其他孤儿核激素受体超家族中高度保守,且在50名正常日本对照个体中未检测到Leu466Arg,因此该突变很可能是X连锁AHC的病因。值得注意的是,在所有已报道的突变中,Leu466Arg位于DAX-1蛋白的最C末端区域。先前鉴定出的大多数突变位于C末端推测的配体结合域。因此,DAX-1蛋白的C末端可能在生物学功能中起重要作用,例如在正常肾上腺胚胎发育中。